You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › February › 23
Gilead
5 months ago
Gilead Sciences said on Monday it will buy cancer therapy partner Arcellx for an implied equity value of $7.8 billion.
page 1 of 1